7-33062850-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001002010.5(NT5C3A):​c.-145G>A variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.694 in 1,413,142 control chromosomes in the GnomAD database, including 342,867 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.69 ( 36292 hom., cov: 32)
Exomes 𝑓: 0.69 ( 306575 hom. )

Consequence

NT5C3A
NM_001002010.5 upstream_gene

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.423

Publications

8 publications found
Variant links:
Genes affected
NT5C3A (HGNC:17820): (5'-nucleotidase, cytosolic IIIA) This gene encodes a member of the 5'-nucleotidase family of enzymes that catalyze the dephosphorylation of nucleoside 5'-monophosphates. The encoded protein is the type 1 isozyme of pyrimidine 5' nucleotidase and catalyzes the dephosphorylation of pyrimidine 5' monophosphates. Mutations in this gene are a cause of hemolytic anemia due to uridine 5-prime monophosphate hydrolase deficiency. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and pseudogenes of this gene are located on the long arm of chromosomes 3 and 4. [provided by RefSeq, Mar 2012]
NT5C3A Gene-Disease associations (from GenCC):
  • hemolytic anemia due to pyrimidine 5' nucleotidase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.709 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NT5C3ANM_001002010.5 linkc.-145G>A upstream_gene_variant ENST00000610140.7 NP_001002010.2 Q9H0P0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NT5C3AENST00000610140.7 linkc.-145G>A upstream_gene_variant 1 NM_001002010.5 ENSP00000476480.2 X6RM59

Frequencies

GnomAD3 genomes
AF:
0.692
AC:
104490
AN:
151106
Hom.:
36252
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.699
Gnomad AMI
AF:
0.502
Gnomad AMR
AF:
0.720
Gnomad ASJ
AF:
0.561
Gnomad EAS
AF:
0.492
Gnomad SAS
AF:
0.603
Gnomad FIN
AF:
0.759
Gnomad MID
AF:
0.608
Gnomad NFE
AF:
0.702
Gnomad OTH
AF:
0.665
GnomAD4 exome
AF:
0.694
AC:
876078
AN:
1261920
Hom.:
306575
AF XY:
0.691
AC XY:
433736
AN XY:
628092
show subpopulations
African (AFR)
AF:
0.703
AC:
20022
AN:
28492
American (AMR)
AF:
0.759
AC:
26685
AN:
35160
Ashkenazi Jewish (ASJ)
AF:
0.559
AC:
13381
AN:
23934
East Asian (EAS)
AF:
0.498
AC:
17399
AN:
34910
South Asian (SAS)
AF:
0.610
AC:
46058
AN:
75486
European-Finnish (FIN)
AF:
0.757
AC:
27138
AN:
35866
Middle Eastern (MID)
AF:
0.612
AC:
2394
AN:
3910
European-Non Finnish (NFE)
AF:
0.708
AC:
687160
AN:
970634
Other (OTH)
AF:
0.670
AC:
35841
AN:
53528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
14075
28150
42224
56299
70374
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16836
33672
50508
67344
84180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.692
AC:
104584
AN:
151222
Hom.:
36292
Cov.:
32
AF XY:
0.693
AC XY:
51198
AN XY:
73930
show subpopulations
African (AFR)
AF:
0.699
AC:
28555
AN:
40864
American (AMR)
AF:
0.720
AC:
10994
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.561
AC:
1941
AN:
3460
East Asian (EAS)
AF:
0.491
AC:
2514
AN:
5116
South Asian (SAS)
AF:
0.605
AC:
2908
AN:
4810
European-Finnish (FIN)
AF:
0.759
AC:
8019
AN:
10564
Middle Eastern (MID)
AF:
0.616
AC:
180
AN:
292
European-Non Finnish (NFE)
AF:
0.702
AC:
47630
AN:
67840
Other (OTH)
AF:
0.660
AC:
1389
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
1585
3170
4755
6340
7925
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
818
1636
2454
3272
4090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.617
Hom.:
1829
Bravo
AF:
0.686

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
7.6
DANN
Benign
0.93
PhyloP100
-0.42
PromoterAI
0.17
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13228639; hg19: chr7-33102462; COSMIC: COSV54238608; API